Oryzon Genomics S.A. (ORYZF)
USD 3.03
(-0.66%)
USD 3.03
(-0.66%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 14.19 Million | 15.69 Million | 10.61 Million | 9.52 Million | 10.27 Million | - |
| Cost of Revenue | 243.69 Thousand | -15.23 Million | -9.86 Million | -8.99 Million | -9.84 Million | -6.48 Million |
| Gross Profit | 13.94 Million | 30.93 Million | 20.48 Million | 18.51 Million | 20.12 Million | 6.48 Million |
| Operating Expenses | 18.49 Million | 20.72 Million | 16.87 Million | 13.28 Million | 13.66 Million | 9.43 Million |
| Selling, General and Administrative Expenses | 3.84 Million | 17.61 Million | 13.06 Million | 9.67 Million | 10.55 Million | 6.68 Million |
| Research and Development Expenses | 15.06 Million | 18.11 Million | 1.63 Million | 1.45 Million | 1.17 Million | 8.47 Million |
| Other Expenses | -414.18 Thousand | -28.6 Thousand | -48.07 Thousand | -23.84 Thousand | -7500.00 | 31.21 Thousand |
| Cost and Expenses | 18.74 Million | 5.48 Million | 7 Million | 4.28 Million | 3.82 Million | 2.94 Million |
| Operating Income | -4.54 Million | -5.48 Million | -7.01 Million | -4.29 Million | -3.83 Million | -2.91 Million |
| Interest Expense | 1.89 Million | 1.11 Million | 455.57 Thousand | 469.08 Thousand | 772.18 Thousand | 803.76 Thousand |
| Income Tax Expense | -2.75 Million | -2.32 Million | -2.49 Million | -1.37 Million | -891.58 Thousand | -2.53 Million |
| Earnings before Tax | -6.1 Million | -6.55 Million | -7.17 Million | -4.77 Million | -4.57 Million | -3.71 Million |
| Net Income | -3.35 Million | -4.23 Million | -4.68 Million | -3.39 Million | -3.68 Million | -1.17 Million |
| Earnings Per Share Basic | -0.06 | -0.08 | -0.09 | -0.06 | -0.08 | -0.03 |
| Earnings Per Share Diluted | -0.06 | -0.08 | -0.09 | -0.06 | -0.08 | -0.03 |
| Weighted Average Shares Outstanding | 60.87 Million | 56.04 Million | 52.76 Million | 52.76 Million | 45.12 Million | 38.45 Million |
| Weighted Average Shares Outstanding (Diluted) | 60.87 Million | 56.04 Million | 52.76 Million | 52.76 Million | 45.12 Million | 38.45 Million |
| Gross Margin | 0.98 | 1.97 | 1.93 | 1.94 | 1.96 | - |
| EBIT Margin | -0.31 | -0.32 | -0.62 | -0.44 | -0.35 | - |
| Profit Margin | -0.24 | -0.27 | -0.44 | -0.36 | -0.36 | - |
| EBITDA | -4.43 Million | -5.35 Million | -6.88 Million | -4.16 Million | -3.69 Million | -3.09 Million |
| Earnings Before Tax Margin | -0.32 | -0.35 | -0.66 | -0.45 | -0.37 | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | 4.1 Million | - | - | - | - |
| Cost of Revenue | - | 170.47 Thousand | - | -13.94 Million | -3.18 Million | -3.41 Million |
| Gross Profit | - | 3.93 Million | - | 13.94 Million | 3.18 Million | 3.41 Million |
| Operating Expenses | 2.79 Million | 1387.18 | 3.49 Million | 18.49 Million | 4.48 Million | 4.18 Million |
| Selling, General and Administrative Expenses | 879 Thousand | 1140.74 | 863 Thousand | - | 1075.18 | 712.47 Thousand |
| Research and Development Expenses | 1.91 Million | 2170.39 | 2.63 Million | - | 3502.73 | 4.03 Million |
| Other Expenses | - | 1.46 Million | 2.4 Million | - | - | - |
| Cost and Expenses | 2.79 Million | 1387.18 | 3.49 Million | 4.54 Million | 1.29 Million | 779.26 Thousand |
| Operating Income | -2.79 Million | -3311.12 | -3.49 Million | -4.54 Million | -1.29 Million | -779.26 Thousand |
| Interest Expense | - | - | - | 1.89 Million | 573.35 Thousand | 264.25 Thousand |
| Income Tax Expense | - | 3416.61 | 140 Thousand | -2.75 Million | -16.36 Thousand | -30.61 Thousand |
| Earnings before Tax | -1.37 Million | 105.49 | -1.09 Million | -6.1 Million | -1.73 Million | -1.09 Million |
| Net Income | -1.37 Million | 107.17 Thousand | -1.23 Million | -3.35 Million | -1.72 Million | -1.06 Million |
| Earnings Per Share Basic | -0.02 | 0.00 | -0.02 | - | -0.03 | -0.02 |
| Earnings Per Share Diluted | -0.02 | 0.00 | -0.02 | - | -0.03 | -0.02 |
| Weighted Average Shares Outstanding | 62.94 Million | 62.94 Million | 61.21 Million | 57.61 Million | 58.45 Million | 58.15 Million |
| Weighted Average Shares Outstanding (Diluted) | 62.94 Million | 62.94 Million | 61.21 Million | 57.61 Million | 58.45 Million | 58.15 Million |
| Gross Margin | - | 0.96 | - | - | - | - |
| EBIT Margin | - | 0.00 | - | - | - | - |
| Profit Margin | - | 0.03 | - | - | - | - |
| EBITDA | -2.79 Million | 3416.61 | -3.49 Million | - | -1.17 Million | -793.23 Thousand |
| Earnings Before Tax Margin | - | -0.00 | - | - | - | - |
HGG
2025
EMCG
XOS
CSBI
3493